Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Biomedical Journal of Indonesia

The Effectiveness of Giving Growth Hormone to Children with Chronic Kidney Disease: Systematic Literature Review Afdhila , Irhamni Nur; Fitrisia Amelin; Gardenia Akhyar
Biomedical Journal of Indonesia Vol. 7 No. 3 (2021): Biomedical Journal of Indonesia
Publisher : Fakultas Kedokteran Universitas Sriwijaya (Faculty of Medicine, Universitas Sriwijaya) Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32539/bji.v7i3.537

Abstract

Chronic Kidney Disease (CKD) can cause growth problems in children. This condition will affect children’s social life and increase morbidity and mortality. Growth hormone (GH) is one of medication that has been used for treatment of impaired growth in children with chronic kidney disease. In Indonesia, this management has not been provided, because it is expensive and its effectiveness is uncertain. This research was conducted to determine the effectiveness of growth hormone in increasing linear growth in children with CKD. This study is a systematic review of the Randomized Controlled Trial (RCT) study to determine the effectiveness of growth hormone as a treatment for children with CKD. Literature search was conducted using five databases, namely Pubmed, Google Scholar, DOAJ, BMC and CENTRAL that matched the inclusion and exclusion criteria. The guide used in the literature selection was the PRISMA flow chart. A Total of 10 studies were included in the systematic review. Growth hormone is effective in increasing linear growth in children with CKD. Generally there was a significant increase in height (standard deviation (SD)), high velocity (SD or cm) in the therapy group compared to the control group. The dose of growth hormone that is given varies, but the most is 4 IU / m2 / day, once a day, by subcutaneous injection. The duration of growth hormone administration varied from 6 months to 5 years with an average of 1.7 years. Growth hormone did not aggravate kidney problems in children with CKD and can increase important factors in bone formation, namely alkaline phosphatase and osteocalcin.
The Effectiveness of Giving Growth Hormone to Children with Chronic Kidney Disease: Systematic Literature Review Irhamni Nur Afdhila; Fitrisia Amelin; Gardenia Akhyar
Biomedical Journal of Indonesia Vol. 7 No. 3 (2021): Vol 7, No 3, 2021
Publisher : Fakultas Kedokteran Universitas Sriwijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32539/bji.v7i3.537

Abstract

Chronic Kidney Disease (CKD) can cause growth problems in children. This condition will affect children’s social life and increase morbidity and mortality. Growth hormone (GH) is one of medication that has been used for treatment of impaired growth in children with chronic kidney disease. In Indonesia, this management has not been provided, because it is expensive and its effectiveness is uncertain. This research was conducted to determine the effectiveness of growth hormone in increasing linear growth in children with CKD. This study is a systematic review of the Randomized Controlled Trial (RCT) study to determine the effectiveness of growth hormone as a treatment for children with CKD. Literature search was conducted using five databases, namely Pubmed, Google Scholar, DOAJ, BMC and CENTRAL that matched the inclusion and exclusion criteria. The guide used in the literature selection was the PRISMA flow chart. A Total of 10 studies were included in the systematic review. Growth hormone is effective in increasing linear growth in children with CKD. Generally there was a significant increase in height (standard deviation (SD)), high velocity (SD or cm) in the therapy group compared to the control group. The dose of growth hormone that is given varies, but the most is 4 IU / m2 / day, once a day, by subcutaneous injection. The duration of growth hormone administration varied from 6 months to 5 years with an average of 1.7 years. Growth hormone did not aggravate kidney problems in children with CKD and can increase important factors in bone formation, namely alkaline phosphatase and osteocalcin.
Co-Authors Abdiana Abdiana, Abdiana Adissa Benanda Afdal Afdal, Afdal Afdhila , Irhamni Nur Afriani, Nita Agustin Vira Agustin Vira Alimuddin Tofrizal Alvarino Alvarino Amel Yanis Amelin, Fitrisia Andani Eka Putra Andrini Ariesti Andrini Ariesti Anum, Qaira Ashal, Taufik Asri, Ennesta Astria Rima Rara Yuswir Astria Rima Rara Yuswir Benanda, Adissa Cimi Ilmiawati, Cimi Dedy Kurnia Desmawati Desmawati Desviorita, Rika Endrinaldi Ennesta Asri Ennesta Asri Erlina Rustam Fathiyyatul Khaira, Fathiyyatul Fauzana Nazifah Fikri Fadhil Fortuna, Fory Gusti Revilla Hendriati, Hendriati Husna, Annisa Tamara Husna, Annisaul I. Izrul Ida Rahmah Burhan Indah Indria Sari Indah Indria Sari Irdawati Izrul Irdawaty Izrul Irhamni Nur Afdhila Izrul, Irdawaty Jefrizal Wirman Julita Julita Julita Julita Julizar Julizar Kemala Sayuti Kurnia, Dedy Lestari, Rahmi M. Ashar Maimi, Afaf Aqil Mardhiati Mardhiati Masrul Meligasari L Gaya Muhamad Firdaus Mutia Sari Nagara, Adianto Jaya Nailatul Fadhila Netti Suharti, Netti Novian Novian Novian Novian Nur, Fauziah Nurul Izzah Putri, Biomechy Oktomalio Rahma Ledika Veroci Raveinal Rendra Darma Satria Rendra Darma Satria Rika Desviorita Rika Desviorita Rina Gustia Rina Gustia Riri Prima Yolanda Rizki Dwayana Rizki Dwayana Rizkia Chairani Asri Salwa Azzahra Satya Wydya Yenny Selfi Renita Rusjdi Shafiqah Zawira Syamel Muhammad Tiffany, Begum Tofrizal Tutty Ariani Tutty Ariani Vesri Yossy Vitresia, Havriza Yenni Raflis Yola Fadilla Yosse Rizal Yulistini, Yulistini Yusticia Katar Yustini Alioes Zafira, Qory